Opioid Indications Under TGA Scrutiny As Australia Tackles Growing Misuse
Executive Summary
The Australian drug regulator is reviewing the indications, pack sizes and information documents for consumers of potent opioid products to see how misuse and overdoses can be prevented.
You may also be interested in...
US FDA To Withdraw Pain Drug Guidance As Part Of Response To Opioid Epidemic
"At least four" guidances will replace it, Commissioner Gottlieb notes in frank update which states "I don’t want to look back ten years from now and wish there were more policies we had pursued, or more steps we had taken, to stop the advance of this crisis."
Eradicating ‘Indication Creep’ One Of Eight Australian Proposals To Tackle Opioid Misuse
Australian regulators are proposing to review the indications of strong opioids to see if they are appropriate, according to one of eight regulatory options for addressing the growing problem of opioid misuse in the country.
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.